Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis.

Sandoo A, Panoulas VF, Toms TE, Smith JP, Stavropoulos-Kalinoglou A, Metsios GS, Gasparyan AY, Carroll D, Veldhuijzen van Zanten JJ, Kitas GD.

J Hum Hypertens. 2011 Nov;25(11):699-702. doi: 10.1038/jhh.2011.36. Epub 2011 Apr 28. No abstract available.

PMID:
21525886
2.

Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.

Hyrich KL, Silman AJ.

J Rheumatol. 2006 May;33(5):831-3. No abstract available.

3.

Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy.

Galarraga B, Belch JJ, Pullar T, Ogston S, Khan F.

J Rheumatol. 2010 Mar;37(3):521-8. doi: 10.3899/jrheum.090417. Epub 2010 Jan 15.

PMID:
20080919
4.

Tumor necrosis factor inhibitors for rheumatoid arthritis.

Scott DL, Kingsley GH.

N Engl J Med. 2006 Aug 17;355(7):704-12. Review. No abstract available.

PMID:
16914706
5.

Estimated medication costs of primary TNFα antagonist failure in patients with rheumatoid arthritis.

Rose E, Lequerré T, Pouplin S, Daragon A, Le Loët X, Vittecoq O.

Joint Bone Spine. 2012 Jul;79(4):421-2. doi: 10.1016/j.jbspin.2012.01.017. Epub 2012 Apr 17. No abstract available.

PMID:
22512937
6.

Antibodies against mutated citrullinated vimentin fail to predict anti-TNFalpha treatment response in rheumatoid arthritis.

Dejaco C, Duftner C, Klotz W, Schirmer M, Herold M.

Scand J Rheumatol. 2009 Jan-Feb;38(1):66-7. doi: 10.1080/03009740802220067. No abstract available.

PMID:
18759163
8.

[Anti-TNF therapy in rheumatoid arthritis].

Yakeuchi T, Amano K.

Nihon Rinsho Meneki Gakkai Kaishi. 2004 Feb;27(1):7-15. Review. Japanese. No abstract available.

9.

Differential drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.

Sidiropoulos PI, Boumpas DT.

Ann Rheum Dis. 2006 Jun;65(6):701-3. No abstract available.

10.

Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis.

Bilsborough W, Keen H, Taylor A, O'Driscoll GJ, Arnolda L, Green DJ.

Rheumatol Int. 2006 Oct;26(12):1125-31. Epub 2006 Jun 24.

PMID:
16799778
11.

Anti-TNF-alpha therapies: they are all the same (aren't they?).

Mpofu S, Fatima F, Moots RJ.

Rheumatology (Oxford). 2005 Mar;44(3):271-3. Epub 2004 Nov 23. Review. No abstract available.

PMID:
15561736
12.

[TNF antagonists in therapy of rheumatoid arthritis].

Oberpichler-Schwenk H.

Med Monatsschr Pharm. 1999 Nov;22(11):334-9. Review. German. No abstract available.

PMID:
10596266
13.

TNF inhibitors: a new age in rheumatoid arthritis treatment.

Anderson DL.

Am J Nurs. 2004 Feb;104(2):60-8; quiz 68-9. Review. No abstract available.

PMID:
14767382
14.

Rheumatoid arthritis.

Burchini G, Orsi C.

N Engl J Med. 2004 Sep 23;351(13):1360-1; author reply 1360-1. No abstract available.

15.

Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register).

Iannone F, Ferraccioli G, Gremese E, Lapadula G; Gruppo Italiano di Studio sulle Early Arthritides (GISEA)..

Ann Rheum Dis. 2014 Jun;73(6):e31. doi: 10.1136/annrheumdis-2013-205011. Epub 2013 Dec 24. No abstract available.

PMID:
24368512
16.

Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors.

Anderson P, Louie J, Lau A, Broder M.

Curr Rheumatol Rep. 2005 Mar;7(1):3-9. Review. No abstract available.

PMID:
15760575
17.

[Pharmacotherapy of rheumatoid arthritis in the era of genetically engineered biological preparations].

Nasonov EL.

Ter Arkh. 2007;79(5):5-8. Russian. No abstract available.

PMID:
17672066
18.

Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.

Dewedar AM, Shalaby MA, Al-Homaid S, Mahfouz AM, Shams OA, Fathy A.

Int J Rheum Dis. 2012 Jun;15(3):330-5. doi: 10.1111/j.1756-185X.2012.01715.x. Epub 2012 Feb 13.

PMID:
22709496
19.

Response to: 'Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)' by Iannone et al.

Neovius M, Askling J.

Ann Rheum Dis. 2014 Jun;73(6):e32. doi: 10.1136/annrheumdis-2013-205037. Epub 2014 Mar 17. No abstract available.

PMID:
24638970
20.

Anti-TNF agents for rheumatoid arthritis.

Seymour HE, Worsley A, Smith JM, Thomas SH.

Br J Clin Pharmacol. 2001 Mar;51(3):201-8. Review. No abstract available.

Supplemental Content

Support Center